Since SOX4, which is overexpressed in breast carcinoma cells, up-regulates the TMEM2 expression by its direct binding to the promoter region20, the increased expression of TMEM2 in carcer cell lines may be explained by the SOX4-mediated pathway20. The gene discussed is CEMIP2; the disease is breast carcinoma.